Mesna and Myoclonus - a phase IV clinical study of FDA data

Summary:

Myoclonus is reported as a side effect among people who take Mesna (mesna), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ondansetron, and have Pain.

The phase IV clinical study analyzes which people have Myoclonus when taking Mesna. It is created by eHealthMe based on reports of 9,641 people who have side effects when taking Mesna from the FDA, and is updated regularly.

What is Mesna?

Mesna has active ingredients of mesna. eHealthMe is studying from 9,647 Mesna users. Check the latest studies of Mesna.

What is Myoclonus?

Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles) is found to be associated with 757 drugs and 1,139 conditions by eHealthMe. Check the latest studies of Myoclonus.

On Jul, 14, 2026

9,641 people reported to have side effects when taking Mesna.
Among them, 14 people (0.15%) have Myoclonus.

Among these 14 people:

How long have people been on Mesna when they have Myoclonus? *

What is the gender of people who have Myoclonus when taking Mesna? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Myoclonus when taking Mesna? *

What are other drugs people take besides Mesna? *

What are other side effects people have besides Myoclonus? *

Confusional State: 6 people, 42.86%
Agitation (state of anxiety or nervous excitement): 2 people, 14.29%
Excessive Eye Blinking (excessive blinking is dry eyes): 2 people, 14.29%
Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups): 2 people, 14.29%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%
Electroencephalogram Abnormal: 2 people, 14.29%
Cardiac Arrest: 2 people, 14.29%
Weakness: 1 person, 7.14%
Encephalopathy (functioning of the brain is affected by some agent or condition): 1 person, 7.14%

What are the existing conditions these people have? *

Pain: 3 people, 21.43%
Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 2 people, 14.29%
Spindle Cell Sarcoma (a type of connective tissue cancer in which the cells): 1 person, 7.14%
Leiomyosarcoma Recurrent (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue repeatedly): 1 person, 7.14%
Breast Cancer: 1 person, 7.14%
Constipation: 1 person, 7.14%
Depression: 1 person, 7.14%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Metastatic Carcinoma Of The Bladder (cancer types can spread to the bladder from other place): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Mesna and have Myoclonus?

- Check whether Myoclonus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mesna:

Mesna (9,647 reports)

Myoclonus treatments and more:

Myoclonus (14,211 reports)

Browse all side effects of Mesna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myoclonus:

Myoclonus (757 drugs)

Browse all the conditions that are associated with Myoclonus:

Myoclonus (1,139 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mesna (the active ingredients of Mesna) and Mesna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.